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10. Hybrid aortic surgery our early experience
Zahid Khan, James Kuo, Jonathan Unswort-White
We report our early experience of hybrid aortic arch
and descending thoracic aortic surgery with/without con-
comitant cardiac procedures.
Between December 2010 and October 2012, 7 patients
underwent hybrid aortic surgery with 4 patients requir-
ing concomitant cardiac procedures (AVR-1, CABG-2
and ascending aortic replacement + CABG-1). There
were 6 males :1 female patient. The operations were per-
formed electively in 5 patients, and as an emergency in 2
patients. All patients underwent relocation of innominate
and right carotid arteries to the proximal ascending aorta
using a 4 side armed Dacron graft, either as a patch or a
tube graft. The left subclavian artery was closed in all
cases either surgically or percutaneously with an amplatz
vascular occlusion device. Following relocation of the
head and neck vessels, the aortic arch and descending
thoracic aorta were stented with either a Medtronic
Thoracic Valiant Aortic Stent (4 cases) or the Jotec
Open E Vita Stent (3 cases). The procedures were carried
out as a one stage operation in 6 cases and as a 2 stage
operation in 1 case. Morbidities include acute renal fail-
ure (1 patient) and left hemiplegia (1 patient). None
developed paraplegia. 1 patient died 2 weeks postopera-
tively from perforated duodenal ulcers.
This technique enables endovascular stenting of the
aortic arch and descending thoracic aneurysms with
concomitant cardiac procedures. The relocation of the
carotid arteries prior to endovascular stenting of the
arch may protect against cerebral embolisation from
atheroma dislodged during antegrade deployment of
the endovascular stent. This technique also allows
antegrade cerebral and coronary perfusion during
circulatory arrest.
Hybrid aortic surgery is a feasible alternative treat-
ment for patients with extensive aortic arch and descend-
ing thoracic aneurysms with concomitant cardiac
pathologies.
http://dx.doi:10.1016/j.jsha.2015.05.191
11. Damus–Kaye–Stansel operation versus bul-
boventricular foramen enlargement for the man-
agement of univentricular heart with systemic
outflow obstruction: 17 years experience, a retro-
spective study
Nabil Albahlooli, Nabil Albahlooli, Sami Alahdal,
Yahya Alfaraidi, Howaida Alqethamy, Abdulraouf
Alsaeedi, Ahmed Elwy, Khaled Alnajashi, Roberto
Di Donato
Background: Subaortic stenosis in a single ventricle mor-
phology can be managed by a Damus–Kaye–Stansel
procedure or by direct bulboventricular foramen (BVF)
resection.We report our results with both techniques in
our center emphasizing pros and cons of either
technique.
Methods: 34 cases with univentricular heart and BVF
obstruction undergoing surgery for subaortic stenosis
during the period between April 1997 and June 2014 were
retrospectively reviewed. Group A (n = 15), receiving a
Damus–Kaye–Stansel procedure and Group B (n = 19),
receiving BVF enlargement.
Results: Median age and median weight at surgery were
34 months (range 7–84 months) and 11 kilograms (range
4–22 kilograms) respectively. There were two early deaths
in Group A (13.3%) and one in Group B (5.3%). No
patient had heart block in the Group A, while two
patients had heart block in Group B (10.5%). One patient
had residual left ventricular outflow obstruction after
BVF enlargement that needed early re-intervention.
New atrio-ventricular valve regurgitation(AVVR)
occurred in one patient of Group A (moderate) and in 8
patients of Group B (mild n = 1, moderate n = 5, severe
n = 2). The median length of hospital stay in Group A
and Group B were 12.5 and 15 days, respectively. The
mean follow up period was 72 ± 56 months (range 1–
199 months). Fontan completion was achieved in 13
patients. No surgical intervention for residual systemic
ventricular outflow obstruction was needed in the follow
up period in either group.
Conclusion: Although both procedures effectively
relieve the obstruction in the systemic outlet chamber,
direct BVF enlargement carries higher risk of heart
block and new AVVR than the Damus–Kaye–Stansel
procedure.
http://dx.doi:10.1016/j.jsha.2015.05.192
12. Percutaneous balloon angioplasty for critical
aortic coarctation in newborns and infants: Is it
still a valid option?
Shehla Jadoon, Milad El-Segaier, Tarek S.
Momenah, M.O. Galal
Background: Coarctation of aorta may present as severe
heart failure in infants and may lead to myocardial dys-
function. Current evidence supports surgical manage-
ment of neonatal coarctation. However, it can be
precarious in critically sick infants.
Aim and objective: To investigate the safety, efficacy,
immediate and mid-term outcome of percutaneous bal-
loon angioplasty (BAP) for infantile aortic coarctation in
critically sick patients.
Methods and patients: Data of all patients under age of
6 months who underwent balloon angioplasty for coarc-
tation were reviewed.
Results: Between January 2008 and April 2014, 15 infants
were identified with coarctation with a mean weight of
3.4 kg (1.4–5 kg) and median age of 54 days (4–142 days).
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